Oric Pharmaceuticals, Inc. Contracts & Agreements
29 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (3)
- Human Resources (11)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (3)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on May 6, 2024)
- Amendment No.1 to the License and Collaboration Agreement by and between the Registrant and Voronoi Inc., effective March 20, 2024 (Filed With SEC on May 6, 2024)
- Amended and Restated 2022 Inducement Equity Incentive Plan, and form agreements thereunder (Filed With SEC on March 29, 2024)
- Stock Purchase Agreement, dated January 20, 2024, by and among the Company and the Purchasers named therein (Filed With SEC on January 22, 2024)
- Securities Purchase Agreement, dated June 24, 2023, by and among the Company and the Purchasers named therein (Filed With SEC on June 27, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 27, 2023)
- License and Collaboration Agreement between the registrant and Voronoi, Inc., dated as of October 19, 2020 (Filed With SEC on May 9, 2022)
- License Agreement between the registrant and Mirati Therapeutics, Inc., dated as of August 3, 2020 (Filed With SEC on May 9, 2022)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 21, 2022)
- Description of the Registrants securities (Filed With SEC on March 21, 2022)
- 2022 Inducement Equity Incentive Plan and related forms of stock option and restricted stock unit agreements (Filed With SEC on March 4, 2022)
- 2020 Employee Stock Purchase Plan and forms of agreement thereunder (Filed With SEC on November 8, 2021)
- First Amendment to Lease between the Registrant and Britannia Pointe Grand Limited Partnership, dated August 12, 2021 (Filed With SEC on August 16, 2021)
- Open Market Sale AgreementSM, dated May 6, 2021, by and between ORIC Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on May 6, 2021)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on November 10, 2020)
- Outside Director Compensation Policy (Filed With SEC on April 20, 2020)
- 2020 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on April 20, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on April 20, 2020)
- Specimen common stock certificate of the Registrant (Filed With SEC on April 20, 2020)
- Form of Underwriting Agreement (Filed With SEC on April 20, 2020)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated June 4, 2019 (Filed With SEC on February 28, 2020)
- Lease between the Registrant and Britannia Pointe Grand Limited Partnership, dated June 5, 2015 (Filed With SEC on February 28, 2020)
- Change in Control and Severance Policy (Filed With SEC on February 28, 2020)
- Executive Incentive Compensation Plan (Filed With SEC on February 28, 2020)
- Employment Letter between the Registrant and Dominic Piscitelli (Filed With SEC on February 28, 2020)
- Employment Letter between the Registrant and Pratik Multani, M.D (Filed With SEC on February 28, 2020)
- Employment Letter between the Registrant and Jacob M. Chacko, M.D (Filed With SEC on February 28, 2020)
- 2014 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on February 28, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on February 28, 2020)
